China Pharma Holdings (CPHI) Net Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
China Pharma Holdings (CPHI) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.39 Bn | 620.63 Bn | 17.26 Bn |
| 2 | AbbVie | 446.71 Bn | 440.14 Bn | 12.70 Bn |
| 3 | Merck | 357.96 Bn | 350.82 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.26 Bn | 260.57 Bn | 11.24 Bn |
| 5 | Pfizer | 156.75 Bn | 145.05 Bn | 10.94 Bn |
| 6 | Sanofi | 52.15 Bn | 44.77 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.08 Bn | 43.08 Bn | - |
| 8 | Incyte | 24.81 Bn | 20.28 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.39 Bn | 18.73 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.61 Mn | 31.30 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11,961.00 |
| Mar 31, 2026 | -8,369.00 |
| Dec 31, 2025 | -5,844.00 |
| Sep 30, 2025 | -4,408.00 |
| Jun 30, 2025 | -5,186.00 |
| Mar 31, 2025 | -3,167.00 |
| Dec 31, 2024 | 50,694.00 |
| Sep 30, 2024 | -7,212.00 |
| Jun 30, 2024 | -12,286.00 |
| Mar 31, 2024 | -5,552.00 |
| Dec 31, 2023 | 9,647.00 |
| Sep 30, 2023 | 3,765.00 |
| Jun 30, 2023 | -2,225.00 |
| Mar 31, 2023 | -1,616.00 |
| Dec 31, 2022 | 18,844.00 |
| Sep 30, 2022 | 2,920.00 |
| Jun 30, 2022 | 2,336.00 |
| Mar 31, 2022 | -3,475.00 |
| Dec 31, 2021 | -1,685.00 |
| Sep 30, 2021 | 1,421.00 |